Clinical trial
A Randomised, Double-blind, Parallel-group, Active Controlled Study Evaluating the Efficacy of Vortioxetine Versus Desvenlafaxine in Adult Patients Suffering From Major Depressive Disorder With Partial Response to SSRI Treatment
NCT04448431 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Parallel-group, Active Controlled Study Evaluating the Efficacy of Vortioxetine Versus Desvenlafaxine in Adult Patients Suffering From Major Depressive Disorder With Partial Response to SSRI Treatment
- Lead sponsor
- H. Lundbeck A/S
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 18, 2020
- Completion date
- February 4, 2022
- Enrollment
- 605 (actual)
- Sites
- 80
Conditions
As the registry lists them; a condition with its own page is linked.